Cargando…
Medication-related osteonecrosis of the jaw: Prosthodontic considerations
Medication-related osteonecrosis of the jaw (MRONJ) can be triggered by several antiresorptive and antiangiogenic medications, including bisphosphonates (BRONJ), denosumab (DRONJ), and other agents used to treat osteoporosis and metastatic bone cancer. Prosthodontists and surgeons continue to face n...
Autores principales: | Ali, Islam E., Sumita, Yuka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693001/ https://www.ncbi.nlm.nih.gov/pubmed/34984072 http://dx.doi.org/10.1016/j.jdsr.2021.11.005 |
Ejemplares similares
-
Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review
por: Kawahara, Mampei, et al.
Publicado: (2021) -
Medication-related osteonecrosis of the jaw: An update
por: Bansal, Hitesh
Publicado: (2022) -
Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
por: Roato, Ilaria, et al.
Publicado: (2023) -
Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations
por: Borgioli, Alberto, et al.
Publicado: (2009) -
Update on Medication Related Osteonecrosis of the Jaws
por: Boyd, Barry C.
Publicado: (2023)